Union City, CA, United States of America

Qiang Wang

This inventor holds 67 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 12 EPO patents, primarily in Optical Communications. Top assignees: Juniper Networks, Inc., Oracle International Corporation, Chemocentryx, Inc.. Active years: 2000-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qiang Wang. Retrieved from https://idiyas.com/inventor/qiang-wang-0fouspa1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 67 (Patent Applications = 11)

% Patents Active = 88.1

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 12 (Patent Applications = 14)

Average Co-Inventor Count = 3.1

ph-index = 13

Forward Citations = 638(Granted Patents)

Location History:

Baltimore, MD (US) (2000)
Redmond, WA (US) (2007 - 2011)
Newark, CA (US) (2002 - 2012)
Union City, CA (US) (2011 - 2021)
Redwood City, CA (US) (2020 - 2022)
Bellevue, WA (US) (2017 - 2024)
Sunnyvale, CA (US) (2019 - 2024)
San Carlos, CA (US) (2019 - 2024)

Company Filing History:

23 out of 4,776

Juniper Networks, Inc.

patents

10 out of 11,892

Oracle International Corporation

Microsoft Technology Licensing, LLC

Apollo Autonomous Driving USA LLC

Johns Hopkins University

patents

10. 1 out of 160

Apollo Intelligent Driving Technology (Beijing) Co., Ltd.

where one patent can have more than one assignee

Years Active: 2000-2026

Loading Chart...

Areas of Expertise:

Firmware Over-The-Air

Autonomous Driving

Video Compression

Optical Networks

Pulse Amplitude Modulation

Bandwidth Limitation

Coherent Optical Transponder

Signal Generation

Raman Gain Monitoring

Power Imbalance

Heteroaryl Sulfonamides

Transmitter Characterization

67 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12675284 - Live upgrade optimizations to reduce downtime (2026-07-07),

2. 12665692 - Optical add drop multiplexers with asymmetrical filtering (2026-06-23),

3. 12654734 - Autonomous driving vehicle as data center infrastructure (2026-06-16),

4. 12566639 - Techniques for auto-tuning compute load resources (2026-03-03),

5. 12547438 - Single hop approach for distributed block storage via a network virtualization device (2026-02-10),

6. 12530219 - Time-bound live migration with minimal stop-and-copy (2026-01-20),

7. 12438806 - Load-based management for NVME over TCP connections (2025-10-07),

8. 12399979 - Provisioning a security component from a cloud host to a guest virtual resource unit (2025-08-26),

9. 12353868 - Firmware over-the-air (FOTA) failure reduction for autonomous driving vehicle (2025-07-08),

10. 12348432 - Bandwidth control inside a shared network interface card (2025-07-01),

11. 12346565 - Persistent memory based caching for intelligent network interface cards (2025-07-01),

12. 12323645 - Scalable video compression accelerator for autonomous driving (2025-06-03),

13. 12107680 - Monitoring burst errors in forward error correction frames (2024-10-01),

14. 12086090 - Uniform virtual bus for system-to-system connectivity in an autonomous driving vehicle (2024-09-10),

15. 12028660 - Cascaded optical switch (2024-07-02),

Title: Innovations and Contributions of Qiang Wang in Optical Communications and Pharmaceutical Research

Introduction: Qiang Wang, a prolific inventor hailing from Union City, California, has made significant strides in the realm of technology and pharmaceuticals. With an impressive portfolio of 32 patents, his innovative approaches have revolutionized how optical communications are conducted and provided new avenues for treating CCR2-mediated diseases.

Latest Patents: Among his latest patents are groundbreaking methods and apparatus for optical communications utilizing pulse amplitude modulation (PAM) in dense wavelength-division multiplexing (DWDM) systems. This innovative method encompasses the application of forward error correction (FEC) using low-density parity-check (LDPC) algorithms to enhance digital signal transmission. Additionally, Qiang Wang has developed heteroaryl sulfonamides that serve as potent antagonists of the CCR2 receptor, demonstrating potential in treating inflammation. These compounds, generally aryl sulfonamide derivatives, not only benefit pharmaceutical compositions but also assist in the identification of CCR2 antagonists through testing.

Career Highlights: Qiang Wang has further expanded his expertise through his work at notable companies such as Juniper Networks, Inc. and Chemocentryx, Inc. His time in these organizations has allowed him to grow as an inventor while contributing to various technological and medicinal advancements.

Collaborations: Throughout his career, Qiang Wang has collaborated with esteemed colleagues including Yang Yue and Antoni Krasinski. These partnerships have fostered a rich exchange of ideas and innovation, facilitating the development of cutting-edge solutions in both optical communications and pharmaceutical research.

Conclusion: Qiang Wang's contributions to the fields of optical communications and medicine underscore his role as a leading inventor. With his extensive patent portfolio and impactful collaborations, he continues to inspire advancements that address contemporary challenges in technology and health.

Profile summary based on public USPTO records.